...
首页> 外文期刊>Oncology letters >Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer
【24h】

Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer

机译:大肠癌患者术前嗜中性白血球比率和血小板淋巴细胞比率作为预后因素的临床意义

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The present study aimed to investigate the independent prognostic values of the pre-operative neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) in patients with colorectal cancer (CRC). The present study retrospectively analyzed the data of 216 patients with CRC from a single hospital. The clinicopathological characteristics of the patients were compared and prognostic factors were evaluated. NLR and PLR were associated with tumor differentiation status and the tumor diameter, respectively, and PLR was also associated with the primary tumor classification (T classification). Furthermore, NLR and PLR were positively associated with each other (R-2=0.5368; P<0.0001). Univariate analyses indicated that stage II and III patients with a high NLR (4.98; P<0.001) or PLR (246.36; P<0.001) possessed a significantly poorer 5-year OS rate compared with those with a low NLR or PLR. Post-operative adjuvant chemotherapy improved the 5-year OS rate in patients with a high NLR or PLR. Multivariate analyses indicated that NLR and PLR were independent prognostic factors [NLR, relative risk (RR)=4.074 and P<0.001; PLR, RR=2.029 and P=0.029] in patients with CRC, and were associated with the T classification, lymph node metastasis and post-operative adjuvant chemotherapy response of patients. Additionally, the area under the curve (AUC) was 0.748 for NLR (95% CI, 0.684-0.804; P<0.0001) and 0.690 for PLR (95% CI, 0.623-0.751; P<0.0001). The RR and AUC indicated that NLR was the superior predictive factor in patients with CRC. In conclusion, the pre-operative NLR and PLR were significant independent prognostic factors in patients with CRC, and NLR was more effective as a prognostic marker compared with PLR. Adjuvant chemotherapy appeared to be more effective in CRC patients with a higher NLR or PLR.
机译:本研究旨在探讨大肠癌(CRC)患者术前中性粒细胞淋巴细胞比(NLR)和血小板淋巴细胞比(PLR)的独立预后价值。本研究回顾性分析了来自一家医院的216例CRC患者的数据。比较患者的临床病理特征并评估预后因素。 NLR和PLR分别与肿瘤分化状态和肿瘤直径相关,PLR也与原发肿瘤分类(T分类)相关。此外,NLR和PLR呈正相关(R-2 = 0.5368; P <0.0001)。单因素分析表明,与低NLR或PLR相比,NLR高(4.98; P <0.001)或PLR(246.36; P <0.001)的II和III期患者的5年OS率显着降低。 NLR或PLR较高的患者,术后辅助化疗可改善5年OS率。多因素分析表明,NLR和PLR是独立的预后因素[NLR,相对危险度(RR)= 4.074,P <0.001。 CRC患者的PLR,RR = 2.029和P = 0.029],并与患者的T分类,淋巴结转移和术后辅助化疗反应相关。此外,曲线下面积(AUC)对于NLR(95%CI,0.684-0.804; P <0.0001)为0.748,对于PLR(95%CI,0.623-0.751; P <0.0001)为0.690。 RR和AUC表明NLR是CRC患者的上佳预测因子。总之,术前NLR和PLR是CRC患者的重要独立预后因素,与PLR相比,NLR作为预后指标更有效。辅助化疗对于NLR或PLR较高的CRC患者似乎更为有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号